Published on: March 9, 2023 Applied Clinical Trials Watch the Full Interview >> Key Learning Objectives: Challenges people encounter when working with RWD How can RWD help address gaps in care? How OM1 engages or supports health equity research using RWD
Tue, Feb 21, 2023 2:00 PM – 3:00 PM EST Presenters: Jessica Paulus, ScD, VP of Research, OM1 and Anna Swenson, Senior Epidemiologist, OM1 Register >> Structured data, what’s found in an electronic medical record or claims, and unstructured data, what’s found in clinician notes, provide valuable insights into treatment effectiveness and safety, gaps in[…]
2022 has been a busy and productive year for OM1 in Real-World Data (RWD), Real-World Evidence (RWE), and Artificial Intelligence (AI). In this debut newsletter, we highlight industry trends and how OM1 is rising to meet those challenges and innovating to develop new opportunities. Please complete the form to download the newsletter. Download >> *Due[…]
View our poster on Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis Patients. Click to view!
View our poster on Effect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical Practice. Click to view more!
